Literature DB >> 20345712

Health-related quality of life among adult patients with moderate and severe von Willebrand disease.

E M de Wee1, E P Mauser-Bunschoten, J G Van Der Bom, M E L Degenaar-Dujardin, H C J Eikenboom, K Fijnvandraat, A de Goede-Bolder, B A P Laros-van Gorkom, K Meijer, H Raat, F W G Leebeek.   

Abstract

SUMMARY
BACKGROUND: von Willebrand Disease (VWD) is the most frequent inherited bleeding disorder. It is unknown how this disorder affects quality of life.
OBJECTIVES: This nationwide multicenter cross-sectional study determined health-related quality of life (HR-QoL) in adult patients with moderate or severe VWD, and assessed whether bleeding severity and type of VWD are associated with HR-QoL.
METHODS: HR-QoL was assessed using the Short Form (SF)-36, and bleeding severity was measured using the Bleeding Score (BS).
RESULTS: Five hundred and nine patients participated; 192 males and 317 females, median age and range 45 (16-87) and 47 (16-84) years, respectively. Compared with the general population, HR-QoL in VWD patients was lower in the vitality domain (61 vs. 66 P < 0.001 for females, 67 vs. 72 P < 0.001 for males). Patients with the most severe bleeding phenotype (highest quartile BS, BS > 17) had a lower HR-QoL in eight domains than patients with a less severe bleeding type (lowest quartile BS, BS < 7) in the univariate analysis. After adjustment for age, gender, co-morbidity and employment/educational status, a more severe bleeding phenotype was associated with lower scores on the domains of physical functioning, role limitations due to physical functioning, bodily pain, general health, social functioning and physical component summary.
CONCLUSIONS: HR-QoL is lower in VWD patients compared with the general population. HR-QoL is strongly associated with bleeding phenotype.

Entities:  

Mesh:

Year:  2010        PMID: 20345712     DOI: 10.1111/j.1538-7836.2010.03864.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  23 in total

1.  An international survey to inform priorities for new guidelines on von Willebrand disease.

Authors:  Mohamad A Kalot; Mohammed Al-Khatib; Nathan T Connell; Veronica Flood; Romina Brignardello-Petersen; Paula James; Reem A Mustafa
Journal:  Haemophilia       Date:  2019-11-26       Impact factor: 4.287

Review 2.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

3.  Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

Authors:  C Rae; W Furlong; J Horsman; E Pullenayegum; C Demers; J St-Louis; D Lillicrap; R Barr
Journal:  Haemophilia       Date:  2012-09-21       Impact factor: 4.287

4.  Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).

Authors:  T C Abshire; A B Federici; M T Alvárez; J Bowen; M D Carcao; J Cox Gill; N S Key; P A Kouides; K Kurnik; A E Lail; F W G Leebeek; M Makris; P M Mannucci; R Winikoff; E Berntorp
Journal:  Haemophilia       Date:  2012-07-23       Impact factor: 4.287

5.  Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease.

Authors:  Igor Govorov; Lena Ekelund; Roza Chaireti; Petra Elfvinge; Margareta Holmström; Katarina Bremme; Miriam Mints
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

6.  von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD.

Authors:  Ferdows Atiq; Lisette M Schütte; Agnes E M Looijen; Johan Boender; Marjon H Cnossen; Jeroen Eikenboom; Moniek P M de Maat; Marieke J H A Kruip; Frank W G Leebeek
Journal:  Blood Adv       Date:  2019-12-23

7.  Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Authors:  N Rydz; J Grabell; D Lillicrap; P D James
Journal:  Haemophilia       Date:  2015-03-10       Impact factor: 4.287

8.  Predictors of quality of life among adolescents and young adults with a bleeding disorder.

Authors:  John M McLaughlin; James E Munn; Terry L Anderson; Angela Lambing; Bartholomew Tortella; Michelle L Witkop
Journal:  Health Qual Life Outcomes       Date:  2017-04-07       Impact factor: 3.186

9.  Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.

Authors:  Heide Siggelkow; Bart L Clarke; John Germak; Claudio Marelli; Kristina Chen; Helen Dahl-Hansen; Elizabeth Glenister; Nawal Bent-Ennakhil; Davneet Judge; Katie Mycock; Jens Bollerslev
Journal:  Clin Endocrinol (Oxf)       Date:  2019-12-11       Impact factor: 3.478

10.  Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.

Authors:  Ferdows Atiq; Karina Meijer; Jeroen Eikenboom; Karin Fijnvandraat; Eveline P Mauser-Bunschoten; Karin P M van Galen; Marten R Nijziel; Paula F Ypma; Joke de Meris; Britta A P Laros-van Gorkom; Johanna G van der Bom; Moniek P de Maat; Marjon H Cnossen; Frank W G Leebeek
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.